Trial intelligence / Profile preview

Dexamethasone for sleep quality and delirium prevention after major urological surgery in older men

IRCT20250623066223N1Phase 3Completed

Sponsor
Shahid Sadoughi University of Medical Sciences
Start
Aug 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative delirium (POD) and sleep disorder comparing Dexamethasone with Normal saline placebo (2 arms). Primary endpoints: Incidence of postoperative delirium and Postoperative sleep quality. Started Aug 2025; status: completed.

02

Drugs

dexamethasone
03

Conditions

postoperative delirium (POD)sleep disorder

Beyond the preview

Go deeper on IRCT20250623066223N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250623066223N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call